Yunnan Baiyao Group Co., Company Profile - Aug 11, 2011 by WrightReports

VIEWS: 27 PAGES: 11

More Info
									Company Fundamentals\Company Profile

   A Wright Investors' Service Research Report:

   Yunnan Baiyao Group Co., Ltd.
                                                                                           440 Wheelers Farms Road
                                                                                           Milford, CT 06461 U.S.A.


  COMPANY PROFILE
  Figures in Chinese Renmimbi

                                 Wright Quality Rating:BAA20                                 Key Data

   Yunnan Baiyao Group Co., Ltd is a China-based company primarily engaged in the            Ticker:
   research, development, manufacture and operation of pharmaceuticals, as well as           000538
   wholesaling and retailing of purchased pharmaceuticals. The Company provides
   traditional Chinese medicines, including Yunnan Baiyao series and natural herbal          2010 Sales:
   medicine series. The Company is also involved in the hotel operation business. As of
                                                                                             10,046,418,174
   December 31, 2010, the Company had 15 subsidiaries and four affiliates, which
   involved in manufacture and sale of pharmaceuticals, as well as securities broking
   and investment business.                                                                  Major Industry:
                                                                                             Drugs, Cosmetics & Health
                       Stock Chart                                    Officers
                                                                                             Care
                                                                     Chairman
                                                                    Minghui Wang
                                                                                             Sub Industry:
                                                                   Vice Chairman             Ethical Drug Manufacturers
                                                                     Huijiang Liu
                                                                                             Country:
                                                               Chief Financial Officer &     China
                                                                      Secretary
                                                                        Wei Wu               Currency:
                                                                                             Chinese Renmimbi

                                                                                             Fiscal Year Ends:
                                                                                             December

                                                                                             Employees
                                                                                             3,828

                                                                                             Exchanges:
                                                                                             SZN
             Stock Price (8/5/2011): 62.50
               Recent stock performance             
								
To top